A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

An HIV antibody achieves potency and breadth by binding simultaneously to two conserved glycans on the viral envelope protein. The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat. Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man9 at 1.65 and 1.29 angstrom resolution, respectively, and glycan binding data delineate a specific high mannose-binding site. Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short β-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify. Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 immunoglobulin Gs may be mediated by cross-linking Env trimers on the viral surface.

[1]  J. Ashby.  References and Notes , 1999 .

[2]  Pham Phung,et al.  Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.

[3]  T. Pierson,et al.  A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus , 2011, PLoS pathogens.

[4]  J. L. Smith,et al.  Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. , 1987, Journal of molecular biology.

[5]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[6]  I. Wilson,et al.  An Insertion Mutation That Distorts Antibody Binding Site Architecture Enhances Function of a Human Antibody , 2011, mBio.

[7]  Robyn L Stanfield,et al.  Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. , 2004, Structure.

[8]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[9]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[10]  Christopher Irving,et al.  Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.

[11]  Martin Phillips,et al.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  John P. Moore,et al.  Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A. , 2006, AIDS research and human retroviruses.

[13]  John P. Moore,et al.  Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.

[14]  David C Montefiori,et al.  Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. , 2010, Virology.

[15]  R. Dwek,et al.  Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. , 2010, Glycobiology.

[16]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[17]  G. Bricogne,et al.  Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. , 2004, Acta crystallographica. Section D, Biological crystallography.

[18]  R. Dwek,et al.  A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. , 1999, Glycobiology.

[19]  N. Grigorieff,et al.  Accurate determination of local defocus and specimen tilt in electron microscopy. , 2003, Journal of structural biology.

[20]  J. L. Raina,et al.  Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.

[21]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[22]  Virginia Pascual,et al.  Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes , 1998, The Journal of experimental medicine.

[23]  D. Erwin,et al.  The Cambrian Explosion: The Construction of Animal Biodiversity. , 2013 .

[24]  Chi-Huey Wong,et al.  Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Donnenberg,et al.  Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes. , 2003, Methods.

[26]  P. Klasse.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. , 2007, Virology.

[27]  E. Rosenberg,et al.  Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals , 2011, Journal of Virology.

[28]  Michael J Taussig,et al.  Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. , 2007, Journal of molecular biology.

[29]  Dennis R. Burton,et al.  A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals , 2010, PLoS pathogens.

[30]  M L Connolly,et al.  The molecular surface package. , 1993, Journal of molecular graphics.

[31]  Pham Phung,et al.  Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.

[32]  Sriram Subramaniam,et al.  Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures , 2011, Proceedings of the National Academy of Sciences.

[33]  Pamela J. Bjorkman,et al.  Few and Far Between: How HIV May Be Evading Antibody Avidity , 2010, PLoS pathogens.

[34]  S. Gordon,et al.  Ligands for the β-Glucan Receptor, Dectin-1, Assigned Using “Designer” Microarrays of Oligosaccharide Probes (Neoglycolipids) Generated from Glucan Polysaccharides* , 2006, Journal of Biological Chemistry.

[35]  Philip G. Evans,et al.  Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions. , 2007, Chemistry & biology.

[36]  L. Morris,et al.  The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.

[37]  W Chiu,et al.  EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.

[38]  Chi-Huey Wong,et al.  Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.

[39]  Tongqing Zhou,et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.

[40]  Ewa Folta-Stogniew,et al.  Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. , 2006, Methods in molecular biology.

[41]  J. L. Le Doux,et al.  Kinetics of retrovirus production and decay. , 1999, Biotechnology and bioengineering.

[42]  Mario Roederer,et al.  Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.

[43]  D. Burton,et al.  Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1 , 2010, Proceedings of the National Academy of Sciences.

[44]  A. M. Lawson,et al.  Neoglycolipid technology: deciphering information content of glycome. , 2003, Methods in enzymology.

[45]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[46]  Ping Zhu,et al.  Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.

[47]  Yukishige Ito,et al.  Synthesis of an octamannosyled glycan chain, the key oligosaccharide structure in ER-associated degradation. , 2003, Carbohydrate research.

[48]  Dennis R. Burton,et al.  Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 , 2010, Journal of Virology.

[49]  Q. Sattentau,et al.  Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.

[50]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[51]  J. Binley,et al.  Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins , 2002, Journal of Virology.

[52]  Tongqing Zhou,et al.  Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.

[53]  D. Burton,et al.  The antiviral activity of antibodies in vitro and in vivo , 2001, Advances in Immunology.

[54]  A. West,et al.  Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10 , 2009, Proceedings of the National Academy of Sciences.

[55]  J. Binley,et al.  A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure , 2000, Journal of Virology.

[56]  I. Wilson,et al.  A Trojan horse with a sweet tooth , 1995, Nature Structural Biology.

[57]  Chao Yang,et al.  SPARX, a new environment for Cryo-EM image processing. , 2007, Journal of structural biology.

[58]  Renate Kunert,et al.  Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies , 2004, Journal of Virology.

[59]  E. Toone.  Structure and energetics of protein-carbohydrate complexes , 1994 .

[60]  Axel T Brunger,et al.  Considerations for the refinement of low-resolution crystal structures. , 2006, Acta crystallographica. Section D, Biological crystallography.

[61]  Yukishige Ito,et al.  High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates. , 2006, Bioorganic & medicinal chemistry.

[62]  Martin Frank,et al.  Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB , 2004, Nucleic Acids Res..

[63]  Wen Jiang,et al.  EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.

[64]  D R Burton,et al.  Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.

[65]  G. Sapiro,et al.  Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.

[66]  R. Wyatt,et al.  Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. , 2005, Virology.

[67]  J. Sodroski,et al.  Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State , 2009, PLoS pathogens.

[68]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[69]  M Radermacher,et al.  DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. , 2009, Journal of structural biology.

[70]  T. Pierson,et al.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. , 2008, Virology.

[71]  A. Trkola,et al.  MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1 , 2011, The Journal of experimental medicine.

[72]  Roland Contreras,et al.  Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Q. Sattentau,et al.  Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.